Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial

por ter Wee, Marieke M, Coupé, Veerle MH, den Uyl, Debby, Blomjous, Birgit S, Kooijmans, Esmee, Kerstens, Pit JSM, Nurmohamed, Mike T, van Schaardenburg, Dirkjan, Voskuyl, Alexandre E, Boers, Maarten, Lems, Willem F
Publicado 2017

Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis

por Markusse, Iris M, de Vries-Bouwstra, Jeska K, Han, K Huub, van der Lubbe, Peter AHM, Schouffoer, Anne A, Kerstens, Pit JSM, Lems, Willem F, Huizinga, Tom WJ, Allaart, Cornelia F
Publicado 2014